Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykinin

This publication has 52 references indexed in Scilit:

• Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on DNA and Collagen Synthesis in Rat Cardiac Fibroblasts
  Hypertension, 2001
• Augmentation of Coronary Blood Flow by Ace Inhibition: Role of Angiotensin and Bradykinin
  Clinical and Experimental Hypertension, 1995
• Bradykinin-mediated effects of ACE inhibition
  Kidney International, 1992
• Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
  Hypertension, 1991
• Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
  Journal of Clinical Investigation, 1985
• Weight and blood pressure. Findings in hypertension screening of 1 million Americans
  JAMA, 1978
• An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive Patients
  New England Journal of Medicine, 1974
• POTENTIAL SCREENING TEST FOR DETECTION OF OVERACTIVITY OF RENIN-ANGIOTENSIN SYSTEM
  The Lancet, 1971
• A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin
  Biochimica et Biophysica Acta (BBA) - Protein Structure, 1970
• SERUM-INSULIN IN ESSENTIAL HYPERTENSION AND IN PERIPHERAL VASCULAR DISEASE
  The Lancet, 1966